HSD11B2 and Other metabolic disease: Taken these observations together with our findings, it is implied that hypomethylation status at the promoter of HSD11B2 may not be among the mechanisms linking intrauterine exposure to maternal preeclampsia and high risk of metabolic diseases in adulthood.